Register for the Webinar
Improving Cancer Care and Drug Development with Methylation Data
Register here
Summary
In this webinar, Evi Lianidou, professor of clinical chemistry at the University of Athens, and Jacob Berchuck, medical oncologist at Dana-Farber Cancer Institute, will discuss how integrating methylation data in liquid biopsy applications can accelerate novel oncology therapeutics development.
Duration: 62 minutes
They will discuss applications including:
- Methylation based gene silencing in breast, prostate, and lung cancer.
- Detecting cell-free DNA based methylation signal for low shedding tumors.
- Identifying novel predictive or prognostic markers to differentiate responders and non-responders.
- Accelerating novel oncology drug development.
Speakers
Evi Lianidou, PhD
Professor of Analytical Chemistry and Clinical Chemistry National and Kapodistrian University of Athens
Evi Lianidou is a professor of analytical chemistry and clinical chemistry in the department of chemistry at the University of Athens.
Jacob Berchuck, MD
Medical Oncologist Dana-Farber Cancer Institute
Jacob Berchuck is a medical oncologist in the Lank Center for Genitourinary Oncology at Dana-Farber Brigham Cancer Center.
Han-Yu Chuang, PhD
Vice President of Technology Guardant Health
Han-Yu Chuang is the vice president of technology at Guardant Health.